Glycine receptor autoantibodies disrupt inhibitory neurotransmission. (2019)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/brain/awz297
PubMed Identifier: 31591639
Publication URI: http://europepmc.org/abstract/MED/31591639
Type: Journal Article/Review
Volume: 142
Parent Publication: Brain : a journal of neurology
Issue: 11
ISSN: 0006-8950